Abstract:Background: Preeclampsia (PE) is a serious idiopathic disease posing a threat to both mothers and fetuses' lives during pregnancy, whose main diagnostic criteria include hypertension with proteinuria. However, American College of Obstetricians and Gynecologists (ACOG) updated the diagnostic criteria for PE and reduced the diagnostic value of proteinuria for patients with PE. Qualitative analysis of the diagnostic value of 24-h proteinuria for patients with PE in China was conducted to evaluate the diagnostic criteria value in the latest ACOG guideline. Methods: Complete clinical data of 65 patients with hypertensive disorder in pregnancy (HDP) were collected. All patients were delivered to and hospitalized in Renji Hospital. Adverse outcome was defined in case of the emergence of any serious complication for a mother or the fetus. A retrospective study was conducted according to ACOG guideline, to analyze the relationship between each diagnostic criteria of ACOG guideline and maternal and perinatal outcomes. Spearman correlation test was used to detect the association between each diagnostic criterion, its corresponding value, and the adverse pregnancy outcome. Logistic regression was performed to verify the result of Spearman correlation test. Results: Of 65 HDP patients, the percentage of adverse pregnancy outcome was 63.1%. Adverse pregnancy outcomes constitute diversification. There were 55 cases with 24-h proteinuria value >= 0.3 g, of which the adverse outcome rate was 74.5%. While adverse pregnancy outcomes did not appear in the rest 10 HDP patients with proteinuria <0.3 g/24 h. The statistic difference was significant (P = 0.000). However, no significant difference was found in other criteria groups (impaired liver function: P = 0.417; renal insufficiency: P = 0.194; thrombocytopenia: P = 0.079; and cerebral or visual symptoms: P = 0.296). The correlation coefficient between 24-h proteinuria = 0.3 g and adverse pregnancy outcomes was 0.557 (P < 0.005). Impaired liver function (P = 0.180), renal insufficiency (P = 0.077) and cerebral or visual symptoms (P = 0.118) were not related to adverse outcomes. The 24-h proteinuria value (HDP: r = 0.685; PE: r = 0.521), liver enzyme value (HDP: r = 0.519; PE: r = 0.501), and creatinine value (HDP: r = 0.511; PE: r = 0.398) were associated with adverse pregnancy outcomes both in PE and HDP, and the corresponding logistic regression equation can be produced. Conclusions: The 24-h proteinuria value is still an important diagnostic criterion for PE, and deletion of 24-h proteinuria value from diagnostic criteria for severe PE was not recommended. The diagnostic criteria in ACOG guideline need to be verified in Chinese women.

Study on relationship between changes of plasma protein in pregnant women with severe preeclampsia and perinatal Outcomes

Study on Correlation between Changes in Coagulation and Fibrinolysis Related Factors and Incidence of Severe Pre-eclampsia

Study on the Relationship Between Severity of Proteinuria and Perinatal Outcomes in Women with Preeclampsia

Clinical Analysis of 26 Cases of Severe Preeclampsia Complicated by Hypoproteinaemia

Alterations in Serum Adipocyte Fatty Acid Binding Protein and Retinol Binding Protein-4 in Normal Pregnancy and Preeclampsia.

Hypoproteinemia as a parameter of poor perinatal/neonatal outcomes in women with preeclampsia diagnosed as hypertension plus proteinuria

Correlation of 24-h Urinary Protein Excretion, Serum Indicators, and Placental Growth Factor in Patients with Preeclampsia and their Adverse Outcome

Influence of low serum-albumin on maternal and neonatal outcomes in severe pre-eclampsia

The association between protein levels in 24-hour urine samples and maternal and neonatal outcomes of pregnant women with preeclampsia

The perinatal examination and outcomes of 431 pregnancies complicated by severe preeclampsia

Comparing Maternal and Perinatal Outcomes in Pregnancies Complicated by Preeclampsia Superimposed Chronic Hypertension and Preeclampsia Alone

Predictive Value of Maternal Serum Biomarkers for Preeclampsia and Birth Weight: A Case-Control Study in Chinese Pregnant Women

Qualitative Analysis of Diagnostic Value of 24-h Proteinuria for Preeclampsia.

Changes of Serum Pregnancy-Associated Plasma Protein-A,Placental Growth Factor and Solu-ble Fms-Like Tyrosine Kinase Receptor-1 Concentrations in Preeclampsia Patients

[Multivariate Analysis of Impacting Perinatal Outcomes in Preeclampsia].

Study on lipid and protein metabolism status of preterm infants whose mothers suffered from pregnancy induced hypertension

Urinary protein and coagulation‐fibrinolysis indicators in preeclampsia: Expression and significance

Proteinuria in preeclampsia: Not essential to diagnosis but related to disease severity and fetal outcomes.

Clinical analysis on 78 cases with early onset severe preeclampsia

Retrospective analysis of perinatal outcomes of singleton pregnant women with early-onset severe preeclampsia superimposed on chronic hypertension

Clinical Study on Severe Pre-eclampsia Preterm Birth and Spontaneous Preterm Birth